• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    48 Biggest Movers From Yesterday

    1/21/22 4:29:26 AM ET
    $APCX
    $APM
    $BBI
    $BBIG
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $APCX alert in real time by email

     


    Check out these big movers of the day

    Check out these penny stocks insiders are buying

    Losers

    • China Finance Online Co. Limited (NASDAQ:JRJC) shares tumbled 38.3% to close at $3.99 on Thursday after the company announced it has received a notice of delisting from Nasdaq.
    • Peloton Interactive, Inc. (NASDAQ:PTON) dipped 23.9% to close at $24.22 following a CNBC report suggesting the company is temporarily halting production of its connected fitness products as a result of waning consumer demand.
    • Valneva SE (NASDAQ:VALN) fell 20.8% to close at $37.66. Valneva shares jumped 45% on Wednesday after results from an initial laboratory study demonstrated that serum antibodies induced by three doses of Valneva's COVID-19 vaccine candidate, VLA2001, neutralize the omicron variant.
    • OceanPal Inc. (NASDAQ:OP) dropped 20.3% to settle at $1.18.
    • Splash Beverage Group, Inc. (NYSE:SBEV) dipped 19.4% to close at $3.19. Splash Beverage Group jumped 22% on Wednesday after the company announced it has received authorization to sell its Pulpoloco Sangria line in 187 of Ralph's Grocery stores.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) dropped 18.5% to close at $3.70. Revelation Biosciences said first group of patients have been dosed in Phase 2b viral challenge study to assess efficacy of intranasal REVTx-99 for the prevention of H3N2 influenza infection.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) fell 18.3% to close at $4.14.
    • Star Equity Holdings, Inc. (NASDAQ:STRR) shares fell 18.1% to close at $1.36 after the company reported pricing of $14.25 million underwritten public offering.
    • BTCS Inc. (NASDAQ:BTCS) dropped 17.3% to close at $5.36.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) dipped 16.7% to close at $5.10 after jumping 45% on Wednesday. EH Hutton, on Tuesday, initiated coverage on the stock with a Buy rating and a $6 price target.
    • EQRx, Inc. (NASDAQ:EQRX) dropped 16.2% to close at $4.55.
    • Leap Therapeutics, Inc. (NASDAQ:LPTX) fell 16.1% to close at $2.39. Leap Therapeutics recently said it will present updated data from the DisTinGuish Phase 2a study of DKN-01, in combination with tislelizumab in gastric or gastric gastroesophageal junction cancer (G/GEJ).
    • TaskUs, Inc. (NASDAQ:TASK) dropped 15.3% to close at $30.13. Spruce Point named the stock as new short call with '50% downside,' setting a $18 price target.
    • Gelesis Holdings, Inc. (NYSE:GLS) fell 15.2% to settle at $4.70.
    • Cardiff Oncology, Inc. (NASDAQ:CRDF) fell 15% to close at $3.87. Cardiff Oncology recently announced data from its lead clinical program evaluating onvansertib in combination with standard-of-care FOLFIRI/bevacizumab.
    • Brickell Biotech, Inc. (NASDAQ:BBI) dropped 15% to close at $0.2601. HC Wainwright & Co recently initiated coverage on the stock with a Buy rating and $2 price target.
    • BT Brands, Inc. (NASDAQ:BTBD) fell 14.7% to close at $2.85.
    • Pluristem Therapeutics Inc. (NASDAQ:PSTI) dropped 14.6% to settle at $1.70.
    • Pluristem Therapeutics and Tnuva recently announced a collaboration to establish a cultured food platform.
    • Nuverra Environmental Solutions, Inc. (NYSE:NES) dipped 13.5% to close at $1.92.
    • ShiftPixy, Inc. (NASDAQ:PIXY) fell 12% to close at $1.47.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) fell 10.7% to close at $0.75. The company announced it received FDA Orphan Drug designation for its multi-antigen target T cell therapy for pancreatic cancer.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 13.3% to close at $3.93 after declining around 13% on Wednesday.
    • Yoshitsu Co., Ltd (NASDAQ:TKLF) shares fell 9.8% to close at $29.53.
    • AppTech Payments Corp. (NASDAQ:APCX) fell 8.9% to close at $1.9946.

    Get the next $APCX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APCX
    $APM
    $BBI
    $BBIG

    CompanyDatePrice TargetRatingAnalyst
    Valneva SE
    $VALN
    4/22/2026$4.90Neutral → Sell
    Goldman
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    TaskUs Inc.
    $TASK
    2/3/2026$15.00Outperform
    Wedbush
    Cardiff Oncology Inc.
    $CRDF
    1/5/2026$12.00Outperform
    Noble Capital Markets
    Peloton Interactive Inc.
    $PTON
    12/10/2025Neutral
    Guggenheim
    TaskUs Inc.
    $TASK
    10/14/2025$18.00Neutral → Outperform
    Robert W. Baird
    Peloton Interactive Inc.
    $PTON
    10/2/2025$8.00 → $9.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $APCX
    $APM
    $BBI
    $BBIG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Peloton Interactive, Inc. Announces Date of Third Quarter Fiscal 2026 Earnings Release and Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ:PTON) will release its third quarter fiscal 2026 financial results before the U.S. stock market opens on Thursday, May 7, 2026. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. ET that day. Peloton's management will answer select questions from retail and institutional investors that are related to the company's business updates and quarterly financial results. If you would like to submit a question for consideration, please use the questionnaire form. A live audio webcast of the conference call will be available on the company's investor relations we

    4/23/26 4:05:00 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026

    SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced it will present updated data from CRDF-004, a randomized dose-finding Phase 2 clinical trial evaluating onvansertib in combination with standard of care (SoC) regimens (FOLFIRI/bevacizumab (bev) or FOLFOX/bev) in patients with first-line RAS-mutated metastatic colorectal cancer (mCRC). The data will be reviewed in a rapid oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29–June 2 in Chicago. Rapid Oral Presentation Details: Abstrac

    4/21/26 10:00:00 AM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TaskUs, Inc. to Announce First-Quarter 2026 Financial Results on May 6, 2026

    TaskUs, Inc. (NASDAQ:TASK), a leading provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, will report its first-quarter financial results after the U.S. market closes on Wednesday, May 6, 2026. The full earnings release, along with supplemental financial data, will be available on the Investor Relations section of the company's website at https://ir.taskus.com under "News & Events." Management will host a conference call and webcast at 5:00 p.m. ET to discuss the company's business, financial results, and 2026 outlook. Investors and other interested parties can access the call and webcast as noted below: What: TaskUs

    4/20/26 9:00:00 AM ET
    $TASK
    EDP Services
    Technology

    $APCX
    $APM
    $BBI
    $BBIG
    SEC Filings

    View All

    SEC Form DEFA14A filed by Cardiff Oncology Inc.

    DEFA14A - Cardiff Oncology, Inc. (0001213037) (Filer)

    4/23/26 4:45:10 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Cardiff Oncology Inc.

    DEF 14A - Cardiff Oncology, Inc. (0001213037) (Filer)

    4/23/26 4:44:20 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Splash Beverage Group Inc. (NV) filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - SPLASH BEVERAGE GROUP, INC. (0001553788) (Filer)

    4/21/26 4:03:39 PM ET
    $SBEV
    Beverages (Production/Distribution)
    Consumer Staples

    $APCX
    $APM
    $BBI
    $BBIG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $9,578 worth of shares (29,606 units at $0.32), increasing direct ownership by 0.91% to 3,300,000 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:57:43 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $31,350 worth of shares (100,000 units at $0.31), increasing direct ownership by 3% to 3,270,394 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/3/26 6:23:42 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $APCX
    $APM
    $BBI
    $BBIG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Valneva SE downgraded by Goldman with a new price target

    Goldman downgraded Valneva SE from Neutral to Sell and set a new price target of $4.90

    4/22/26 7:54:11 AM ET
    $VALN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Peloton downgraded by Argus

    Argus downgraded Peloton from Buy to Hold

    2/10/26 7:17:53 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Peloton with a new price target

    Telsey Advisory Group reiterated coverage of Peloton with a rating of Market Perform and set a new price target of $6.00 from $8.00 previously

    2/6/26 6:46:09 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $APCX
    $APM
    $BBI
    $BBIG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Kirol Charles Peter

    4 - PELOTON INTERACTIVE, INC. (0001639825) (Issuer)

    4/22/26 4:16:17 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    SEC Form 4 filed by Doyle John Brendan

    4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)

    4/20/26 4:18:30 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Ricciardi Lisa

    4 - COGNITION THERAPEUTICS INC (0001455365) (Issuer)

    4/20/26 4:16:28 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APCX
    $APM
    $BBI
    $BBIG
    Financials

    Live finance-specific insights

    View All

    Peloton Interactive, Inc. Announces Date of Third Quarter Fiscal 2026 Earnings Release and Conference Call

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ:PTON) will release its third quarter fiscal 2026 financial results before the U.S. stock market opens on Thursday, May 7, 2026. The company will host a conference call and live audio webcast to discuss the financial results at 8:30 a.m. ET that day. Peloton's management will answer select questions from retail and institutional investors that are related to the company's business updates and quarterly financial results. If you would like to submit a question for consideration, please use the questionnaire form. A live audio webcast of the conference call will be available on the company's investor relations we

    4/23/26 4:05:00 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    TaskUs, Inc. to Announce First-Quarter 2026 Financial Results on May 6, 2026

    TaskUs, Inc. (NASDAQ:TASK), a leading provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, will report its first-quarter financial results after the U.S. market closes on Wednesday, May 6, 2026. The full earnings release, along with supplemental financial data, will be available on the Investor Relations section of the company's website at https://ir.taskus.com under "News & Events." Management will host a conference call and webcast at 5:00 p.m. ET to discuss the company's business, financial results, and 2026 outlook. Investors and other interested parties can access the call and webcast as noted below: What: TaskUs

    4/20/26 9:00:00 AM ET
    $TASK
    EDP Services
    Technology

    Cognition Therapeutics CEO Issues Letter to Shareholders

    Advancing Zervimesine (CT1812) towards late-stage trials for dementia with Lewy bodies (DLB) psychosis Fully funded $80 million Phase 2 START trial readout expected in the second half of 2027 PURCHASE, N.Y., March 31, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ:CGTX), a clinical-stage neuroscience company developing drugs that treat neurodegenerative disorders, has published CEO Lisa Ricciardi's Letter to Shareholders. The full text of the letter follows. A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER To my fellow Shareholders, We made significant progress in 2025 towards our goal of developing transformative treatments for neurodegenerative diseases. As discussed on our

    3/31/26 4:30:00 PM ET
    $CGTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APCX
    $APM
    $BBI
    $BBIG
    Leadership Updates

    Live Leadership Updates

    View All

    Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

    Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive OfficerAppoints industry veterans Josh Muntner as Chief Financial Officer and Ajay Aggarwal, MD, MBA, as Chief Operating Officer SAN DIEGO, April 09, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ:CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced the appointment of Mani Mohindru, PhD, as President and Chief Executive Officer (CEO), following her time as Interim CEO, and that she will continue as a member of the Board. The Company also appointed Josh Muntner as Chief Financial Officer and Ajay Aggarwal, M

    4/9/26 4:01:00 PM ET
    $CRDF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

    Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today a

    3/18/26 5:31:30 PM ET
    $MRKR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $APCX
    $APM
    $BBI
    $BBIG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:13:58 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary